Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CHRISTOPHER V POOLE

Allopathic & Osteopathic Physicians Internal Medicine Nephrology

NPI
1558368837
CMS profile
342656
Location
CHATTANOOGA, TN

General Payments · PY2018–2024

$1,043.82

  • Reported across 62 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$225.13

11 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $200.52 10
Education $24.61 1

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $79.40 5
PY2019 $245.34 18
PY2020 $76.53 5
PY2021 $90.71 5
PY2022 $313.49 17
PY2023 $13.22 1
PY2024 $225.13 11

Payment records · PY2024 (11)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AKEBIA THERAPEUTICS INC $24.61 11/20/2024 Education Undisputed 01/23/2026 1145834449 CMS
AstraZeneca Pharmaceuticals LP $18.14 04/23/2024 Food and Beverage Undisputed 01/23/2026 1104426243 CMS
AstraZeneca Pharmaceuticals LP $21.62 05/28/2024 Food and Beverage Undisputed 01/23/2026 1105569339 CMS
AstraZeneca Pharmaceuticals LP $15.83 11/19/2024 Food and Beverage Undisputed 01/23/2026 1105448611 CMS
Aurinia Pharma U.S., Inc. $16.91 08/12/2024 Food and Beverage Undisputed 01/23/2026 1150689825 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $14.50 07/30/2024 Food and Beverage Undisputed 01/23/2026 1118057015 CMS
CALLIDITAS THERAPEUTICS US INC. $28.41 07/22/2024 Food and Beverage Undisputed 01/23/2026 1141518889 CMS
GENZYME CORPORATION $27.22 04/05/2024 Food and Beverage Undisputed 01/23/2026 1139677211 CMS
Novo Nordisk Inc $18.15 09/30/2024 Food and Beverage Undisputed 01/23/2026 1097060410 CMS
Otsuka America Pharmaceutical, Inc. $25.98 11/03/2024 Food and Beverage Undisputed 01/23/2026 1118962645 CMS
Ultragenyx Pharmaceutical Inc. $13.76 05/01/2024 Food and Beverage Undisputed 01/23/2026 1153287652 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.